Impact of prolonged isolation on adolescents with drug-susceptible tuberculosis in Lima, Peru: a qualitative study

被引:8
|
作者
Rapoport, Victoria Elena Oliva [1 ]
Altamirano, Elmer [2 ]
Senador, Liz [2 ]
Wong, Milagros [2 ]
Beckhorn, Catherine B. [2 ]
Coit, Julia [3 ]
Roche, Stephanie D. [4 ]
Lecca, Leonid [2 ,3 ]
Galea, Jerome T. [3 ,5 ]
Chiang, Silvia S. [1 ,6 ]
机构
[1] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Socios Salud Sucursal Peru, Lima, Peru
[3] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA
[4] Fred Hutchinson Canc Res Inst, Div Publ Hlth Sci, Seattle, WA USA
[5] Univ S Florida, Sch Social Work, Tampa, FL 33620 USA
[6] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI 02903 USA
来源
BMJ OPEN | 2022年 / 12卷 / 09期
基金
美国国家卫生研究院;
关键词
Tuberculosis; Public health; PAEDIATRICS; International health services; Infection control; Paediatric infectious disease & immunisation; CHILDHOOD; BARRIERS;
D O I
10.1136/bmjopen-2022-063287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Patients with tuberculosis (TB) generally are instructed to isolate at the beginning of treatment in order to prevent disease transmission. The duration of isolation varies and may be prolonged (ie, lasting 1 month or more). Few studies have examined the impact of isolation during TB treatment on adolescents, who may be more vulnerable to its negative effects. Methods This study took place from 2018 through 2019 in Lima, Peru, where the Ministry of Health mandates the exclusion of patients with TB from educational institutions for at least 2 months. Using semi-structured guides, we conducted individual in-depth interviews with adolescents who received treatment for drug-susceptible TB, their primary caregivers and health providers. We performed thematic analysis of the transcribed interviews. Results We interviewed 85 participants: 34 adolescents, 36 caregivers and 15 healthcare workers. At the time of their TB diagnoses, 28 adolescents were in secondary, postsecondary, vocational or military school. Adolescents with drug-susceptible TB were prescribed home isolation usually for 2 (and occasionally for 1) months. Consequently, they could neither attend school nor socialise with family members or friends. Two primary themes emerged from the interviews. First, as a result of their exclusion from school, most adolescents fell behind academically and had to repeat a semester or academic year. Second, absence from school, separation from friends and loved ones, and reinforcement of TB-related stigma (arising from fear of TB transmission) harmed adolescents' mental health. Conclusion Prolonged isolation led to educational setbacks and emotional trauma among adolescents with TB. Prolonged isolation is not supported by current evidence on TB transmission and is problematic from a human rights perspective, as it violates adolescents' rights to education and freedom of movement. Isolation recommendations should be re-evaluated to align with data on TB transmission and the principles of patient-centred care.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
    Payam Nahid
    Leah G Jarlsberg
    Irina Rudoy
    Bouke C de Jong
    Alon Unger
    L Masae Kawamura
    Dennis H Osmond
    Philip C Hopewell
    Charles L Daley
    BMC Infectious Diseases, 11
  • [22] Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis
    L. Fox
    M. R. Kramer
    I. Haim
    R. Priess
    A. Metvachuk
    D. Shitrit
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30
  • [23] Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients
    Salazar-Austin, Nicole
    Mulder, Christiaan
    Hoddinott, Graeme
    Ryckman, Theresa
    Hanrahan, Colleen F.
    Velen, Kavindhran
    Chimoyi, Lucy
    Charalambous, Salome
    Chihota, Violet N.
    PATHOGENS, 2022, 11 (11):
  • [24] Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
    Chang, Vincent K.
    Imperial, Marjorie Z.
    Phillips, Patrick P. J.
    Velasquez, Gustavo E.
    Nahid, Payam
    Vernon, Andrew
    Kurbatova, Ekaterina V.
    Swindells, Susan
    Chaisson, Richard E.
    Dorman, Susan E.
    Johnson, John L.
    Weiner, Marc
    Sizemore, Erin E.
    Whitworth, William
    Carr, Wendy
    Bryant, Kia E.
    Burton, Deron
    Dooley, Kelly E.
    Engle, Melissa
    Nsubuga, Pheona
    Diacon, Andreas H.
    Nhung Nguyen Viet
    Dawson, Rodney
    Savic, Radojka M.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review
    Chimeh, R. A.
    Gafar, F.
    Pradipta, I. S.
    Akkerman, O. W.
    Hak, E.
    Alffenaar, J-W. C.
    van Boven, J. F. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (08) : 811 - +
  • [26] Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China
    WANG Ni
    MA Yan
    LIU YU Hong
    DU Jian
    ZHANG Hui
    XIE Shi Heng
    Zhu Kun
    LYU Xiao Ya
    SHU Wei
    WANG Hong Hong
    ZHU Guo Feng
    TAN Shou Yong
    FU Yan Yong
    MA Li Ping
    ZHANG Lian Ying
    LIU Fei Ying
    HU Dai Yu
    ZHANG Yan Ling
    LI Xiang Qun
    LI Liang
    BiomedicalandEnvironmentalSciences, 2016, 29 (08) : 612 - 617
  • [27] Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis
    Lee, Hyun
    Sohn, Jang Won
    Sim, Yun Su
    Shin, Tae Rim
    Kim, Dong-Gyu
    Choi, Hayoung
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [28] Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis
    Velasquez, Gustavo E.
    Nahid, Payam
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (07) : 816 - 818
  • [29] First data of a quabodepistat containing novel regimen for drug-susceptible tuberculosis
    Naidoo, Kogieleum
    Perumal, Rubeshan
    LANCET INFECTIOUS DISEASES, 2025, 25 (04): : 366 - 367
  • [30] Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis
    Choi, H.
    Lee, H.
    Sim, Y.
    Shin, T.
    Kim, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199